New company to use technology developed by Nano Terra to improve performance and cut costs of solar cells.
Neue Version des Vorsorgerasters ‘Synthetische Nanomaterialien’
Der Vorsorgeraster fuer synthetische Nanomaterialien erlaubt Industrie und Gewerbe ein strukturiertes Vorgehen zum Erkennen moeglicher Risiken im Umgang mit synthetischen Nanomaterialien.
Quantenpunkte aus Indiumarsenid auf Silizium-Wafern
Wissenschaftler des Helmholtz-Zentrums Dresden-Rossendorf koennen Quantenpunkte aus Indiumarsenid auf Silizium-Wafern erzeugen. Das Besondere: Sie verwenden dabei Verfahren, die schon jetzt in der Halbleiterfertigung eingesetzt werden.
Single-molecule nanoelectronics is getting closer to reality
Using single molecules as electronic components like diodes, switches or transistors is the ultimate goal for future electronic nanotechnology devices. In order to explore the electronic properties of a single molecule, researchers have to make electrical contact between electrodes and molecules - and this has proven to be a big challenge. Though many efforts have been made to realize single-molecule electronics, it is still impossible to fabricate a practical single-molecule integrated circuit. One of the problems is the lack of viable methods for wiring each functional molecule. Researchers have now demonstrated a novel method for controlling single molecule chemical reactions - a kind of 'chemical soldering'.
Nanotechnologie stoppt Rost und Verschleiss
Werterhaltung von Konsum- und Industrieguetern durch Nanotechnologie massgeblich foerdern. Neue Web-Publikation liefert aktuelle Informationen.
Insect virus holds the key to safer stem cell therapy
Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed a new genetic engineering technique that promises safer stem cell therapy for cancer patients.
An unexpected clue to thermopower efficiency
Berkeley Lab scientists find that uneven temperature can lead to electronic whirlpools and sideways magnetic fields.
Ecology Coatings Nominated for the Michigan Green Chemistry Award Program
Ecology Coatings, Inc., a leader in the discovery and development of nanotechnology-enabled, ultraviolet-curable advanced coatings, today announced that it has been nominated for the Michigan Green Chemistry Governor's Award Program for 2011.
Sun-free photovoltaics
Materials engineered to give off precisely tuned wavelengths of light when heated are key to new high-efficiency generating system.
Multifunctional nanotechnology tool simplifies design and study of nanostructures
Basic operations in the field of nanotechnology that are currently very difficult or impossible to perform can become easy with a new multi-nano tool called FIBLYS. Nanosized components in for example solar cells will be designed and studied in an entirely new way, which the researchers hope will increase the solar cells' energy output with up to 15 percent.
Artificial cilia spur new thinking in nanotechnology (w/video)
Due to the importance of ciliary functions for health, there is great interest in understanding the mechanism that controls the cilias' beating patterns. But learning exactly how cilia movement is coordinated has been challenging. That may be beginning to change as a result of the creation, by a team of Brandeis researchers, of artificial cilia-like structures that dramatically offers a new approach for cilia study.
Single-molecule magnets encapsulated inside carbon nanotubes
Single-molecule magnets (SMM) are fascinating nanoscale structures with unique functional properties showing promise for high-density electronic data storage devices, solid state quantum computers, spintronic devices such as spin valves, and other advanced technological applications. Despite a flurry of research in this area - since an individual magnetic molecule represents the ultimate size limit to storing and processing information - the main challenge related to harnessing properties of SMM remained unsolved. A new study by a group of European researchers reports the successful encapsulation of single-molecule magnets in carbon nanotubes, yielding a new type of hybrid nanostructure that combines all the key single-molecule magnet properties of the guest molecules with the functional properties of the host CNT.
Merck and Nano-C, Inc. Jointly Develop New-Generation Materials for Organic Photovoltaic Applications
Merck KGaA announced it has signed a collaboration agreement with Nano-C, Inc. of Westwood, MA, United States, a leading developer of nanostructured carbon for use in energy and electronics applications. Both companies aim to jointly develop and commercialize advanced semiconducting materials and formulations for applications in organic photovoltaics.
Nanowire electronics that can be shaped to fit any surface and attach to any material (w/video)
Electronic circuitry composed of nanowires can now be fitted to a surface of almost any shape on an object made of virtually any material, using a new approach to fabrication and transfer of nanowire electronics developed by Stanford researchers.
New invisibility cloak hides objects from human view
For the first time, scientists have devised an invisibility cloak material that hides objects from detection using light that is visible to humans. The new device is a leap forward in cloaking materials.
New distributorship announcement: Aperio
Genecompany is now the sole distributor for Aperio in Hong Kong and China.
We’re pleased to inform that Genecompany is now the authorized distributor for Aperio in Hong Kong and China. With this agreement, Genecompany now offer our customers the Aperio‘s products which are the only complete solution for digital pathology over the world.
Courtesy of Gene Company.
Farewell Walter Reed Hospital
After more than 100 years of active operations, Walter Reed Army Medical Center lowered its flag for the last time as activities transition to the newly constructed Walter Reed National Military Medical Center in neighboring Bethesda, MD.
The hospital was known for both treating U.S. presidents and high ranking military and civilian officials and scandal alike.
Truth be told, I wanted to go to Hawaii, California or Colorado where there were active Army hospitals with pathology residency programs. By the time I finished medical school and internship, those programs were closed.
Walter Reed was one of the Army pathology programs that remained and we stayed at Walter Reed for 9 years were I completed my internship, residency and had my first job in practice.
Some of the best years of my life, personally and professionally, although I don't think I appreciated it at the time. The day I started "clearing post" was the day the BRAC list come out with Walter Reed's name on it. 6 years later, much like AFIP as well which was an installation on the Walter Reed campus, has closed down its operations.
What military medicine offers trainees and physicians is a camaraderie and sense of group effort that is hard to match in civilian medicine. Within the military healthcare system you were able to practice medicine. No asking permission from insurance companies for approvals, no reimbursement issues that directly impacted you or issues with hospital contracts, payers, payees, etc... Nevermind you were fortunate enough to take care of soldiers, sailors, airmen, marines -- people charged with defending our country at times with personal sacrifice and taking care of their families who counted on these individuals to be safe from harm.
Hard to imagine people actually told me ten years ago the government would never close Walter Reed or AFIP.
Times change.
What if the cure for cancer were discovered tomorrow?
There is a quote I heard or saw a number of years ago that says something like "Medicine, the only profession that labors incessantly to destroy the reason for its own existence".
Recently ESPN went through a telethon for the Jimmy V Foundation and the ESPY awards and celebration always receive mention of Coach Jim Valvano and his famous "Never Give Up" speech.
Occasionally, I think of Dr. Randy Pausch and his "Last Lecture" speech.
These men and countless others, both patients, families, friends and providers have strived to raise money to find cancer cures.
What if the cure for cancer were discovered tomorrow? And the efforts of tens of thousands of volunteers, researchers, organizers, physicians, politicians, deans and bureaucrats saw to it that a cure could be found.
Of course, one of the reasons a cure for cancer has not been discovered despite countless hours and trillions in funding worldwide is that cancer is not a single disease, it is very heterogeneous, even among cancers that involve the same organ or organ system.
For the sake of argument what if the cures for colon, lung, breast and prostate cancer were discovered tomorrow?
How long would it be before the cure was validated by groups outside those making the initial claim and the product brought to market?
Would the cure treat only those diagnosed with the disease or could it be taken to prevent the disease?
Ask this question of anyone in passing (at least for me when I talk to folks in healthcare, laboratories, fellow pathologists) and you will hear "I would be out of a job". But would they?
What would a cure do to the economics of healthcare as it pertains to oncology diagnostics, therapeutics, oncologic surgery, radiation and management of known complications of the disease and its treatments?
What effect would the saved lives that may have been lost due to population statistics and what impact would that have on other diseases and medical specialties? Fewer oncology visits may mean increased cardiology referrals as one example. Would it be too late for me to do a cardiology fellowship?
Future posts will try to tackle some of these hypothetical scenarios based on known facts, figures, costs and population models. If you know of any good sources, please let me know.
Indica Labs extends In situ hybridization capabilities with automated quantification of dual ISH assays
Albuquerque, New Mexico 7/26/2011 – Indica Labs, inc. announces new capabilities for measuring dual ISH assays for the purpose of measuring gene amplification in tumors and other tissues. The new, fully automated and quantitative solution allows researchers and pathologists to measure dual ISH assays, such as those provided by leading reagent manufacturers, with the single click of a button rather than having to manually count spots which is an arduous process. The software rapidly counts dual probe signals and reports ratios between probes on a per cell basis. This automated approach is not only faster and less error prone than manual interpretation of the assays, it also generates additional data such as signal ratios and signal counts at the cellular level in addition to the specimen or tumor level data. This additional level of detail is useful in measuring the cellular heterogeneity within tumors. Indica Labs, CEO Steven Hashagen stated:
“We are excited about expanding our ISH quantification capabilities. The use of brightfield ISH assays is increasingly becoming more main-stream and image analysis software dramatically simplifies the work involved for scoring these assays. Moreover, the use of dual ISH kits makes image analysis quantification even more of a necessity than before.”
This latest release of Indica's ISH software is highly configurable such that it can be used to measure a wide range of reagent kits, tissue types, and image file formats. Prior to this announcement, Indica Labs’ product offering included several other tools for measuring just single probe CISH, SISH, and RNA ISH assays. To learn more about any of the ISH quantification products visit http://indicalab.com/products.html. Additionally, Indica Labs and Aperio presented all of these capabilities in a complementary webinar that aired on July 21st. To view a recording of the webinar, visit http://www.aperio.com/pathology-events/webinar_events.asp.
###
About Indica Labs, Inc.
Indica Labs provides sophisticated pathology image processing software for whole slide tissue analysis. Indica Labs' software tools seamlessly integrate into leading digital pathology platforms to provide reproducible and highly quantitative data to pathologists in hospitals, academic medical centers, government research institutions, global pharmaceutical companies, and small biotech firms. For more information, please visit http://www.indicalab.com. Indica Labs products are intended for research use only.
Contact
Indica Labs, Inc. info@indicalab.com
PathXL Performance Acceleration – Upgrade For All PathXL Users
i-Path is pleased to introduce improved performance for PathXL platform, available to all customers from the 20th July 2011. This upgrade will bring noticeable benefits for i-Path customers who use PathXL for research, education and clinical purposes.
The PathXL acceleration integrates with the PathXL Image Server to speed up the delivery of digital images. From 20th July 2011 images will be provided to the customer using a faster network connection (gigabit) and intelligent algorithm compression techniques. Current PathXL users will experience noticeable improvements, with instantaneous image viewing on suitable bandwidth networks.
All i-Path hosted customers will benefit immediately from this upgrade with no additional effort required from the side of the customer.
Please contact the i-Path Support Team for more information.
